Dr.Rathnakar U.P.
16
MD.DIH.PGDHM
Receptors - distribution
1 -Heart, JG cells in kidney 2 -Blood vessels, sk.muscles, eye.Bronchi
[Uterus, liver, GIT, GUT]
Beta blockers-classification
14
Nonselective (1 and 2) a. Without intrinsic sympathomimetic activity PROPRANOLOL, Sotalol, Timolol. b. With intrinsic sympathomimetic activity Pindolol c. With blocking property Labetalol, Carvedilol Cardioselective (1) METOPROLOL, Atenolol, Acebutolol, Bisoprolol, Esmolol, Betaxolol, Celiprolol, Nebivolol
13
Beta blockers
Beneficial effects Antihypertensive In myocardial ischemia Antiarrhythmic In CHF Anxiety Migraine Glaucoma ADEs Bronchospasm Blunts symptoms of hypoglycemia and delays recovery Muscle fatigue
12
11
10
Symp.overactivity Acute- blockers worsen Stable CHF- long term benefits by reducing 1activity Reverse remodeling, improve patient symptoms, prevent hospitalization, and prolong life
blood flow
BA more with food
ADEs
Sudden withdrawalexacerbation of angina Reduced ex.capacity Worsening of PVD Not related to beta blockadeG.I.T, nightmares, insomnia, loss of memory, sexual distress in males Practolol bannedocculomucocutaneous syndrome
hypoglycemia
Exacerbates variant angina Adverse lipid profile [cardio selective & Pindolol safe]
5
1 selective Safe in COPD Safe in diabetics Less peripheral action on BV[safe in pts with PVD] Lipid profile not affected Cannot suppress tremors Less effect on ex.capacity
Less bradycardia at rest Less withdrawal effect [ continued agonistic action] Not effective in migraine[dilate cerebral vessels] Not in MI
Membrane stabilizing
[Propranolol]
Better arrhythmic activity???????
With blockade
Labetolol & Carvedilol [also antioxidant]
Muscle tremors
Thyrotoxic crisis
Glaucoma